Red Herring Top 100 award for BMEYE

 Red Herring's Top 100 Europe list has become a mark of distinction for identifying promising new companies and entrepreneurs.

"We are very proud to be selected as a Red Herring Top 100 company", said Rob de Ree, CEO of BMEYE. "It is a very valuable recognition for the organization as a whole and for the breakthrough technology that improves patient care and which will change medical practice. This award further drives and inspires the BMEYE team to successfully implement programs to accelerate clinical adoption."

"Choosing the companies with the strongest potential was by no means a small feat," said Alex Vieux, publisher and CEO of Red Herring. "After rigorous contemplation and discussion, we narrowed our list down from hundreds of candidates from across Europe to the Top 100 Winners. We believe BMEYE embodies the vision, drive and innovation that define a successful entrepreneurial venture. BMEYE should be proud of its accomplishment, as the competition was very strong."

BMEYE is the premier provider and will set the standard of noninvasive, beat-to-beat, user-friendly cardiovascular monitoring systems, to improve patient care and reduce healthcare costs. BMEYE, a Dutch based company in Amsterdam, develops and markets innovative medical technology with broad applications in a variety of clinical settings. The Nexfin(TM) family of monitors uses an easy to apply finger sensor to produce accurate beat-to-beat, noninvasive blood pressure and cardiac output data displayed on an intuitive touch screen.